According to a senior trade official, investor protections in the TPP will not hinder Australia's ability to regulate in the public interest. In addition, the TPP will not require Australia to make adjustments to health or drug approval processes.
Read the full article at tpptreaty.com.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
